<DOC>
	<DOC>NCT00739440</DOC>
	<brief_summary>The purpose of this study is to compare the efficiency and safety of the treatment against sting scorpion, using two serums, one elaborated by Birmex versus other commercial serum</brief_summary>
	<brief_title>Randomized Controlled Trial to Compare Two Anti-scorpion Serums</brief_title>
	<detailed_description>We consider relevant conduct this study because the poisoning scorpion bite represents a public health problem. This is a randomized clinical trial, which included 120 subjects of both sexes aged 15 and 60 years old and residents of the state of Guanajuato, divided into 2 groups: 60 patients received antiscorpion serum of Birmex and 60 patients receive other commercial serum.</detailed_description>
	<mesh_term>Scorpion Stings</mesh_term>
	<criteria>Sting scorpion Informed consent Age 1560 Either sex Resident in study area Previous treatment with gammaglobulin Blood transfusion at any stage of life Sensitivity or intolerance to serums antiscorpion or horse products Pregnancy Some immunodeficiency</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>